Allergen-specific immunotherapy is the only causal therapy of Immunoglobulin E-induced
allergies like allergic rhinoconjunctivitis. Despite progress during the last decades it is
limited by a long treatment time and high non-responder frequency. Based on experimental and
epidemiological evidences we hypothesize that vitamin D can act as an effective
immunomodulatory adjuvant to overcome these limitations.
Phase:
Phase 2
Details
Lead Sponsor:
Charite University, Berlin, Germany
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins